Bone reports

The most recent articles from: Bone Rep December 2016

Bone reports · Dec 2016

Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia.

X-linked hypophosphatemia (XLH) is characterized by lower extremity deformities that lead to bone and/or joint pain that result from decreased renal tubular reabsorption leading to hypophosphatemia caused by elevated levels of fibroblast growth factor 23 (FGF23).

expand abstract… mark as read…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.